In HCC, loss of SIRT5 results in M2 macrophage polarization and impaired CD8+ surveillance, whereas the inhibition of bile-acid signaling restores immune responsiveness and improves anti-PD-1 efficacy (156, 158). Here, SIRT5 is linked to hepatocellular carcinoma.